Age-related Macular Degeneration (AMD)

Around 675,000 people in the UK have late-stage AMD, which is the most common cause of sight loss in the UK and the developed world. AMD progressively impacts the centre of the visual field, ultimately depriving its patients from most everyday tasks like reading, driving, or even recognising faces.

Currently there is no treatment for the majority of AMD patients. Only 10% of AMD patients, those with a type of the condition called ‘wet AMD’ can be treated with regular injections of a drug into the eye.

Action Against AMD was founded by leading sight loss charities (including Macular Society, Sight Scotland Veterans, and Blind Veterans UK) to join efforts in identifying new interventions to stop the progression of AMD as early as possible, before it leads to sight loss.

Affiliate charities

Our Future Health is joining with many of the UK’s leading health research charities who are providing valuable support and expertise to help develop Our Future Health. They will make a big impact in allowing us to ultimately change the way we prevent, detect and treat diseases.

Andrew Roddam, CEO of Our Future Health, said: “We are delighted to have the support of AAAMD as an affiliate charity of Our Future Health. We look forward to working in partnership to ensure Our Future Health provides new opportunities in AMD research, to ultimately help prevent sight loss.”

Wen Hwa Lee, CEO of AAAMD, said: “Preserving health instead of trying to revert diseases will be the most important step in the future of medicine and healthcare – Our Future Health is the fundamental foundation for such transformation. We couldn’t have found a better partner to jointly create a tomorrow where AMD will become a condition of the past.”

Learn more

Read more about our partnerships.